Ring Therapeutics
Cambridge, United States· Est.
Ring Therapeutics is developing a platform of commensal viruses, called Anelloviruses, for gene therapy and vaccine delivery.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $86.5M
About
Ring Therapeutics is developing a platform of commensal viruses, called Anelloviruses, for gene therapy and vaccine delivery.
Gene TherapyVaccinesPlatform
Funding History
1Total raised:$86.5M
Series C$86.5M